Orchard Therapeutics Announces Positive Clinical and Preclinical Data in Programs…
<!-- Name:DistributionId Value:8842747 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
ASGCT
Voyager Therapeutics Presents Robust, Multi-Species Results from Preclinical Studies…
<!-- Name:DistributionId Value:8841596 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Locanabio Presents Preclinical Data from its Vectorized snRNA Exon Skipping Program…
<!-- Name:DistributionId Value:8840184 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
BridgeBio Pharma to Present Updated Data from its BBP-812 Canavan Disease Gene…
<!-- Name:DistributionId Value:8838681 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and…
<!-- Name:DistributionId Value:8830693 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:True -->…
Adverum Biotechnologies Announces Upcoming Data Presentations at ASGCT 2023 including…
<!-- Name:DistributionId Value:8830389 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:True -->…
uniQure Announces Major Presence at Upcoming American Society of Gene and Cell…
<!-- Name:DistributionId Value:8830430 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:True -->…
Dyne Therapeutics to Present New Preclinical Data at ASGCT Annual Meeting…
<!-- Name:DistributionId Value:8830457 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Adverum Presents Data at ASGCT Further Supporting Phase 2 Development Plans for…
- Human equivalent ADVM-022 dose of 6E10 vg/eye provided therapeutic levels of aflibercept in NHPs - Oral encore presentation to highlight ADVM-022 reductions in mean annualized…
Caribou Biosciences Presents Data on Mechanism Underlying Superior Specificity of…
BERKELEY, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the…